Treatment for Reducing Respiratory Distress in COVID-19 Patients
A simple LMWHA diagnostic could be used as a companion diagnostic to identify responders to N-butyryl HA therapy
Published: 10th June 2021

Patents
- US 9,644,050 “Hyaluronic Acid Derivatives”
- Japanese Patent JP6363119B2
- Canadian Patent 2,905,610 "Hyaluronic Acid Derivatives"
- Patents pending on use in gout, hyperuricemia and wound healing in US, Canada and China
IP Status
- Patented
- Provisional patent
Seeking
- Development partner
- Seeking investment